Dr Jennifer Soon
Honorary Fellow
Faculty of Medicine, Dentistry and Health Sciences
23 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review
DOI: 10.1016/j.ejca.2025.1161322025
Journal article
1645P A phase Ib study to evaluate the safety, tolerability and efficacy of the combination of encorafenib, binimetinib and palbociclib in patients with BRAF-mutant metastatic melanoma (CELEBRATE)
DOI: 10.1016/j.annonc.2025.08.22732025
Conference Proceedings
Unmet need in healthcare: Ambiguity in the definition does not help setting priorities
2024
Journal article
Leveraging the potential for deintensification in cancer care
DOI: 10.1038/s43018-024-00827-92023
Journal article
A tailored approach to horizon scanning for cancer medicines
DOI: 10.1016/j.jcpo.2023.1004412023
Journal article
PRIMCAT: A novel approach to informing health technology assessment decision making in Australia
DOI: 10.1016/j.annonc.2023.09.26412022
Journal article
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
DOI: 10.1016/j.dib.2022.108649
RECENT SCHOLARLY WORKS
2022
Journal article
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study
DOI: 10.1016/j.ejca.2022.08.0092022
Conference Proceedings
CELEBRATE: A phase 1b study to evaluate the safety, tolerability and preliminary efficacy of the Combination of Encorafenib, Binimetinib and Palbociclib in patients with BRAF-mutant metastatic melanoma (The CELEBRATE study)
2022
Journal article
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
DOI: 10.1016/j.annonc.2022.06.004